What is Pediatric Oncology?
- Definition: The medical specialty dedicated to the diagnosis, treatment, and long-term follow-up of cancers of the urinary system (male and female) and the male reproductive organs.
- Primary Goal:To achieve effective tumor eradication while prioritizing the preservation of urinary function, sexual potency, and overall quality of life.
Key Procedures (Treatment)
- Surgery (Minimal Invasion): Procedures performed by specialized Uro-Oncologic Surgeons, including Robotic Prostatectomy, Partial Nephrectomy (kidney removal), and Cystectomy (bladder removal).
- Radiation Therapy (Precise & Targeted): Used for localized cancers, often involving Brachytherapy (internal radiation for prostate cancer) or external beam radiation (IMRT/SBRT).
- Systemic Therapy (Chemotherapy/Immunotherapy): Drugs used for advanced or metastatic disease, particularly in bladder and kidney cancer. Immunotherapy is a major advancement for kidney and bladder cancer.
- Active Surveillance: A monitoring approach for very low-risk cancers (especially Prostate cancer), involving regular tests and biopsies instead of immediate aggressive treatment.
Palliative & Supportive Care
- Sexual & Urinary Rehabilitation: Intensive post-treatment therapy (e.g., pelvic floor exercises, PDE5 inhibitors) to recover continence and sexual function, especially after prostatectomy.
- Hormone Deprivation Therapy (ADT): Management of side effects related to hormonal treatment used for prostate cancer (e.g., fatigue, hot flashes, bone density loss).
- Pain Management: Comprehensive pain control for advanced disease, focusing on bony or visceral pain related to metastases.
- Stoma Care: Specialized training and support for patients who have undergone urinary diversion (creating an external pouch) after bladder removal.
Benefits of Specialized Uro Oncology
- Functional Preservation Focus: Utilizes techniques (like nerve-sparing surgery and focal therapy) designed specifically to minimize impact on continence and sexual health.
- Access to Novel Systemic Agents: Expertise in delivering cutting-edge Immunotherapy and Targeted Agents (especially for kidney and bladder cancers) that have high response rates.
- Multidisciplinary Tumor Board: Case discussions involving Urologist, Radiation Oncologist, and Medical Oncologist to determine the optimal, integrated treatment plan.
- Improved Quality of Life Outcomes: Specialized follow-up programs are dedicated to addressing long-term genitourinary and hormonal side effects, ensuring better post-treatment adjustment.
Step 1: Definition & Location
Focuses on tumors arising in the urinary tract (Kidneys, Bladder, Ureters) and the male reproductive organs (Prostate, Testicles). Common types include Prostate, Bladder, and Kidney cancer.